Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Prop 65 suit names 56 supplement firms

This article was originally published in The Tan Sheet

Executive Summary

The California attorney general alleges 56 multivitamin marketers violated the state's Proposition 65 by failing to warn that their products included lead. The AG filed the suit Dec. 23 after the Carrick Law Group sent notices to 74 companies the FDA identified as having lead in their multivitamins (1"The Tan Sheet" Aug. 11, 2008, p. 8). The complaint does not name 14 of the companies identified in FDA's study because they have fewer than 10 employees and are not subject to Prop 65, which requires companies to warn when products include chemicals that could cause cancer or reproductive problems

You may also be interested in...

FDA Survey Shows Lead Labeling Not Needed For Supplements – Stakeholders

FDA's survey of lead contamination in hundreds of women's and children's vitamin supplements found what many industry stakeholders expected - lead levels in vitamins are not a cause for concern

Changing Of The Guard At Merck KGaA With Garijo Succeeding Oschmann As CEO

The appointment of Belén Garijo as CEO of the German major from May next year is a small but significant step on the road to addressing gender inequality at the very top level of management in the world of big pharma.

FDA Talks Tough On Complete Response Extensions

The FDA has published fresh guidance taking a tougher stance on sponsor reasons for needing more time to respond to complete response letters.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts